Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases : One Test is Not Enough
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 22(2024), 2 vom: 15. Feb., Seite 420-422.e2 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lapp, Sean L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 29.01.2024 Date Revised 18.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cgh.2023.06.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358329655 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358329655 | ||
| 003 | DE-627 | ||
| 005 | 20240218231841.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cgh.2023.06.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1298.xml |
| 035 | |a (DE-627)NLM358329655 | ||
| 035 | |a (NLM)37331412 | ||
| 035 | |a (PII)S1542-3565(23)00481-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lapp, Sean L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases |b One Test is Not Enough |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.01.2024 | ||
| 500 | |a Date Revised 18.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Infliximab |2 NLM | |
| 650 | 7 | |a B72HH48FLU |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 700 | 1 | |a Bewtra, Meenakshi |e verfasserin |4 aut | |
| 700 | 1 | |a Lewis, James D |e verfasserin |4 aut | |
| 700 | 0 | |a SPARC IBD Investigators |e verfasserin |4 aut | |
| 700 | 1 | |a Kaur, Manreet |e investigator |4 oth | |
| 700 | 1 | |a Dassopoulos, Themistocles |e investigator |4 oth | |
| 700 | 1 | |a Snapper, Scott B |e investigator |4 oth | |
| 700 | 1 | |a Korzenik, Joshua R |e investigator |4 oth | |
| 700 | 1 | |a Bohm, Matthew |e investigator |4 oth | |
| 700 | 1 | |a Raffals, Laura |e investigator |4 oth | |
| 700 | 1 | |a Poonam, Beniwal-Patel |e investigator |4 oth | |
| 700 | 1 | |a Hudesman, David |e investigator |4 oth | |
| 700 | 1 | |a Russ, Kirk |e investigator |4 oth | |
| 700 | 1 | |a Brook, Loren |e investigator |4 oth | |
| 700 | 1 | |a Pekow, Joel |e investigator |4 oth | |
| 700 | 1 | |a Cross, Raymond |e investigator |4 oth | |
| 700 | 1 | |a Wong, Uni |e investigator |4 oth | |
| 700 | 1 | |a Bishu, Shrinivas |e investigator |4 oth | |
| 700 | 1 | |a Bewtra, Meenakshi |e investigator |4 oth | |
| 700 | 1 | |a Lewis, James D |e investigator |4 oth | |
| 700 | 1 | |a Duerr, Richard |e investigator |4 oth | |
| 700 | 1 | |a Saha, Sumona |e investigator |4 oth | |
| 700 | 1 | |a Caldera, Freddy |e investigator |4 oth | |
| 700 | 1 | |a Scoville, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a Deepak, Parakkal |e investigator |4 oth | |
| 700 | 1 | |a Ciorba, Matthew |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association |d 2003 |g 22(2024), 2 vom: 15. Feb., Seite 420-422.e2 |w (DE-627)NLM147178851 |x 1542-7714 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2024 |g number:2 |g day:15 |g month:02 |g pages:420-422.e2 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cgh.2023.06.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2024 |e 2 |b 15 |c 02 |h 420-422.e2 | ||